Additive effects of fatty acid mixtures on the levels and ratio of amyloid β40/42 peptides differ from the effects of individual fatty acids

Journal of Neuroscience Research

Volumn 89, Issue 11, 2011, Pages 1795-1801

  Amtul, Zareen ^a   Uhrig, Markus ^a   Beyreuther, Konrad ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alzheimer's disease; Amyloid ; Cell culture; Fatty acid mixture

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; ARACHIDONIC ACID; FATTY ACID; GAMMA SECRETASE; LINOLEIC ACID; OLEIC ACID; OMEGA 6 FATTY ACID;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; LIPID COMPOSITION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; ARACHIDONIC ACID; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; FATTY ACIDS; LINOLEIC ACID; OLEIC ACID; PEPTIDE FRAGMENTS;

EID: 80052526143     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22706     Document Type: Article

References (33)

1. Amtul Z, Uhrig M, Supino R, Beyreuther K. 2010a. Phospholipids and a phospholipid-rich diet alter the in vitro amyloid-beta peptide levels and amyloid-beta 42/40 ratios. Neurosci Lett 481: 73-77.
2. Amtul Z, Westaway D, Cechetto DF, Rozmahel RF. 2011. Oleic acid ameliorates amyloidosis in cellular and mouse models of Alzheimer's disease. Brain Pathol 21: 321-329.
3. Amtul Z, Uhrig M, Rozmahel RF, Beyreuther K. 2011. Structural insight into the differential effects of omega-3 and omega-6 fatty acids on the production of Aβ peptides and amyloid plaques. J Biol Chem 286: 6100-6107.
4. Gu Y, Nieves JW, Stern Y, Luchsinger JA, Scarmeas N. 2010. Food combination and Alzheimer disease risk: a protective diet. Arch Neurol 67: 699-706.
5. Guan Z, Wang Y, Cairns NJ, Lantos PL, Dallner G, Sindelar PJ. 1999. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J Neuropathol Exp Neurol 58: 740-747.
6. Hartmann T, Bergsdorf C, Sandbrink R, Tienari PJ, Multhaup G, Ida N, Bieger S, Dyrks T, Weidemann A, Masters CL, Beyreuther K. 1996. Alzheimer's disease betaA4 protein release and amyloid precursor protein sorting are regulated by alternative splicing. J Biol Chem 271: 13208-13214.
7. Hashimoto M, Hossain S, Agdul H, Shido O. 2005a. Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions. Biochim Biophys Acta 1738: 91-98.
8. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O. 2005b. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 135: 549-555.
9. Hu FB. 2002. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol 13: 3-9.
10. Ida N, Hartmann T, Pantel J, Schroder J, Zerfass R, Forstl H, Sandbrink R, Masters CL, Beyreuther K. 1996. Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem 271: 22908-22914.
11. Jensen M, Hartmann T, Engvall B, Wang R, Uljon SN, Sennvik K, Naslund J, Muehlhauser F, Nordstedt C, Beyreuther K, Lannfelt L. 2000. Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systems. Mol Med 6: 291-302.
12. Kelicen P, Nordberg A. 2006. Feedback regulation of SREBP and aromatase in A beta(25-35)-supplemented human neuroblastoma cells. Cell Mol Neurobiol 26: 225-235.
13. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. 1998. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95: 6448-6453.
14. Lichtenthaler SF, Ida N, Multhaup G, Masters CL, Beyreuther K. 1997. Mutations in the transmembrane domain of APP altering gamma-secretase specificity. Biochemistry 36: 15396-15403.
15. Lichtenthaler SF, Beher D, Grimm HS, Wang R, Shearman MS, Masters CL, Beyreuther K. 2002. The intramembrane cleavage site of the amyloid precursor protein depends on the length of its transmembrane domain. Proc Natl Acad Sci U S A 99: 1365-1370.
16. Liu Y, Yang L, Conde-Knape K, Beher D, Shearman MS, Shachter NS. 2004. Fatty acids increase presenilin-1 levels and γ-secretase activity in PSwt-1 cells. J Lipid Res 45: 2368-2376.
17. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. 1985. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82: 4245-4249.
18. Matsumoto Y, Yamaguchi T, Watanabe S, Yamamoto T. 2004. Involvement of arachidonic acid cascade in working memory impairment induced by interleukin-1 beta. Neuropharmacology 46: 1195-1200.
19. Mattson MP. 2004. Pathways toward and away from Alzheimer's disease. Nature 430: 631-639.
20. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL. 1999. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46: 860-866.
21. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K. 1993. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 301: 41-52.
22. Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, Leenders I, Broersen L, Lutjohann D, Hartmann T, Tanila H. 2006. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 23: 563-572.
23. Ou J, Tu H, Shan B, Luk A, DeBose-Boyd RA, Bashmakov Y, Goldstein JL, Brown MS. 2001. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci U S A 98: 6027-6032.
24. Patil S, Chan C. 2005. Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons. Neurosci Lett 384: 288-293.
25. Patil S, Sheng L, Masserang A, Chan C. 2006. Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons. Neurosci Lett 406: 55-59.
26. Prasad MR, Lovell MA, Yatin M, Dhillon H, Markesbery WR. 1998. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 23: 81-88.
27. Smedman M, Potempska A, Rubenstein R, Ju W, Ramakrishna N, Denman RB. 1997. Effects of cadmium, copper, and zinc and beta APP processing and turnover in COS-7 and PC12 cells. Relationship to Alzheimer disease pathology. Mol Chem Neuropathol 31: 13-28.
28. Srinivasan BD, Kulkarni PS. 1989. Inhibitors of the arachidonic acid cascade in the management of ocular inflammation. Prog Clin Biol Res 312: 229-249.
29. St. George-Hyslop PH. 2000. Piecing together Alzheimer's. Sci Am 283: 76-83.
30. Tagawa K, Maruyama K, Ishiura S. 1992. Amyloid beta/A4 precursor protein (APP) processing in lysosomes. Ann N Y Acad Sci 674: 129-137.
31. Townsend KP, Pratico D. 2005. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J 19: 1592-1601.
32. Willett WC. 1998. Nutritional epidemiology. New York: Oxford University Press.
33. Wilson DM, Binder LI. 1997. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am J Pathol 150: 2181-2195.